Masako Mori
Impact in
- Virology top 10%
- HIV Research and Treatment
- Toxicology top 10%
- Bioactive Compounds and Antitumor Agents
Papers in
-
- Glycosylation and Glycoproteins Research 7
- Bone Metabolism and Diseases 2
-
- Carbohydrate Chemistry and Synthesis 2
- Co-authors
- Toshihiro Miyazaki (5 shared papers)Toshihisa Komori (5 shared papers)Takeshi Moriishi (4 shared papers)Carolina A. Yoshida (3 shared papers)Hisato Komori (3 shared papers)Yoshio Koyanagi (1 shared paper)Chiaki Nishitani (1 shared paper)Masaki Kurogochi (4 shared papers)
- Journals
- PLoS ONE (2 papers)Journal of Histochemistry & Cytochemistry (1 paper)Glycobiology (1 paper)Bioscience Biotechnology and Biochemistry (1 paper)Cancer Research (1 paper)
- Partner nations
- JapanSouth Korea
In The Last Decade
Masako Mori
21 papers receiving 434 citations
Peers
Comparison fields: 5 of 67
- Virology 44
- Toxicology 22
- Immunology 98
- Biotechnology 34
- Molecular Biology 228
Countries citing papers authored by Masako Mori
This map shows the geographic impact of Masako Mori's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masako Mori with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masako Mori more than expected).
Fields of papers citing papers by Masako Mori
This network shows the impact of papers produced by Masako Mori. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masako Mori. The network helps show where Masako Mori may publish in the future.
Co-authors
The 25 scholars most cited alongside Masako Mori, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 79 | |
| 2 | 2012 | 79 | |
| 3 | 2010 | 65 | |
| 4 | 2012 | 33 | |
| 5 | Prognostic markers for patient outcome following vaccination with multiple MHC Class I/II-restricted WT1 peptide-pulsed dendritic cells plus chemotherapy for pancreatic cancer. | 2015 | 27 |
| 6 | 2010 | 20 | |
| 7 | 2004 | 20 | |
| 8 | 1996 | 20 | |
| 9 | 1998 | 19 | |
| 10 | 2014 | 16 | |
| 11 | 2017 | 13 | |
| 12 | 2002 | 11 | |
| 13 | 2000 | 10 | |
| 14 | 2015 | 9 | |
| 15 | 2014 | 6 | |
| 16 | 2018 | 5 | |
| 17 | 2011 | 4 | |
| 18 | 2021 | 2 | |
| 19 | 2014 | 1 | |
| 20 | 2012 | 1 |
About Masako Mori
Masako Mori is a scholar working on Molecular Biology, Organic Chemistry, Radiology, Nuclear Medicine and Imaging, Immunology and Oncology, having authored 21 papers that have together received 441 indexed citations. Recurring topics across this work include Glycosylation and Glycoproteins Research (7 papers), Monoclonal and Polyclonal Antibodies Research (4 papers), Galectins and Cancer Biology (2 papers), Axon Guidance and Neuronal Signaling (2 papers), Carbohydrate Chemistry and Synthesis (2 papers), Bioactive Compounds and Antitumor Agents (2 papers), Bone Metabolism and Diseases (2 papers) and HIV Research and Treatment (2 papers). The work is most often cited by research in Virology (44 citations), Toxicology (22 citations), Immunology (98 citations), Biotechnology (34 citations) and Molecular Biology (228 citations). Masako Mori has collaborated with scholars based in Japan and South Korea. Frequent co-authors include Toshihiro Miyazaki, Toshihisa Komori, Takeshi Moriishi, Carolina A. Yoshida, Hisato Komori, Yoshio Koyanagi, Chiaki Nishitani, Masaki Kurogochi, Hiroyuki Itabe and Osamu Morikawa. Their work appears in journals such as PLoS ONE, Journal of Histochemistry & Cytochemistry, Glycobiology, Bioscience Biotechnology and Biochemistry and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.